Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5275425

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
C[C@@H]1O[C@@H](OC2=C(c3ccc(O)c(O)c3)Oc3cc(O)cc(O)c3[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O

Basic Information

ChEMBL ID CHEMBL5275425
Phase Preclinical
Structure Type MOL
InChI Key FIRXIZPRZDHLER-IPGYZZKOSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

450.4
MW (Da)
0.15
ALogP
11
HBA
8
HBD
189.5
PSA (Ų)
0.30
QED
2
Ro5 Violations
3
Rot. Bonds

Drug Information

Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C21H22O11
MW 450.40
Aromatic Rings 2
Heavy Atoms 32
NP-Likeness 1.90

Activity Summary

IC50 1 meas. best 4.14

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Sortase A
CHEMBL5362
IC50 4.14 4.14 71800.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Sortase A IC50 = 71800.0 nM 4.14 Inhibition of Staphylococcus aureus SrtA using EDANS-Dabcyl as substrate by FRET... 34516107

Literature References

PubMed DOI Target Context # Activities
34516107 10.1021/acs.jmedchem.1c00386 Sortase A 1

Data from ChEMBL 36 via Core Engine